Cell / Gene Therapy Stocks
7 stocks · Healthcare sector · flow as of Oct 20, 2026 close
Cell / Gene Therapy stocks: what the data says
As of the Oct 20, 2026 close, NextPick's Cell / Gene Therapy basket shows neutral (flow score -3). That is the 51st-strongest money flow of 110 industry baskets tracked. The basket was up 3.6% on the day and up 4.0% over five sessions.
The basket holds 7 Cell / Gene Therapy stocks in the Healthcare sector. The largest by market cap are CRSP, BEAM and VCEL. The median member is down 3.1% over the past month. Best one-month returns: PRME (+22.9%), VCEL (+2.6%) and BEAM (−1.3%). Weakest: FATE (−18.6%), CRSP (−14.5%) and EDIT (−8.8%). On the latest close, 3 members showed inflow and 2 showed outflow.
Cell / Gene Therapy stocks list
| Stock | Market cap | Close | 1D | 1M | 3M | Money flow |
|---|---|---|---|---|---|---|
| CRSP stockCRISPR Therapeutics AG | $4.8B | $49.88 | -0.32% | -14.49% | +5.59% | weak outflow |
| BEAM stockBeam Therapeutics Inc.BEAM earnings | $2.4B | $24.93 | +3.06% | -1.31% | -6.42% | outflow |
| VCEL stockVericel Corporation | $2.1B | $40.58 | +0.52% | +2.60% | -8.93% | weak inflow |
| NTLA stockIntellia Therapeutics, Inc.NTLA earnings | $1.6B | $11.84 | +2.25% | -3.11% | +6.38% | neutral |
| PRME stockPrime Medicine, Inc. | $629M | $3.92 | +2.35% | +22.88% | +26.86% | weak inflow |
| EDIT stockEditas Medicine, Inc. | $361M | $2.58 | +6.61% | -8.83% | -7.19% | weak inflow |
| FATE stockFate Therapeutics, Inc. | $214M | $2.06 | +10.75% | -18.58% | -20.16% | neutral |
Cell / Gene Therapy money flow, last 10 sessions
| Session | Flow score | Signal | Basket 1D |
|---|---|---|---|
| Oct 20, 2026 | -3 | neutral | +3.60% |
| Oct 19, 2026 | -18 | weak outflow | +3.42% |
| Oct 16, 2026 | -5 | neutral | -3.68% |
| Oct 15, 2026 | -3 | neutral | +4.33% |
| Oct 14, 2026 | -12 | weak outflow | -3.28% |
| Oct 13, 2026 | -8 | neutral | -5.28% |
| Oct 12, 2026 | -12 | weak outflow | -3.59% |
| Oct 9, 2026 | 13 | weak inflow | +4.30% |
| Oct 8, 2026 | 33 | inflow | -0.61% |
| Oct 7, 2026 | 23 | weak inflow | -0.35% |
Cell / Gene Therapy stocks: key questions
What are the biggest Cell / Gene Therapy stocks?
By market cap, the largest Cell / Gene Therapy stocks NextPick tracks are CRISPR Therapeutics AG (CRSP), Beam Therapeutics Inc. (BEAM), Vericel Corporation (VCEL), Intellia Therapeutics, Inc. (NTLA) and Prime Medicine, Inc. (PRME).
Is money flowing into Cell / Gene Therapy stocks?
On the Oct 20, 2026 close, flow is roughly balanced: the basket reads neutral with a flow score of -3, up 3.6% on the day.
Which Cell / Gene Therapy stocks performed best this month?
Over the past 21 sessions the leaders are PRME (+22.9%), VCEL (+2.6%) and BEAM (−1.3%).
Baskets and money-flow scores are NextPick's own sector-flow model built from daily price and volume data; they describe past trading and are not investment advice.